FIZ Researches on Kabasura Kudineer Tablets From Sri Sri Tattva, a Classical Siddha Formulation on its Role in SARS CoV2 Inhibition
| Tuesday | 1st December, 2020
Sri Sri Tattva has always approached it’s intiatives with a scientific temperament.
It is a good initiative of Sri Sri Tattva to get this in Tablet form," Dr. Kanakavalli, DG CCRS, Chennai.
Gurudev Sri Sri Ravi Shankar addressing the Press on traditional system of Ayurvedic medicineAmong them, a pivotal research study by Frankfurt Innovation Center for Biotechnology (FIZ) shows that the efficacy of Sri Sri Tattva Kabasur Kudineer Tablet, a classical Siddha formulation, along with other Ayurveda medicines (Sri Sri Tattva Amruth Tablet, Sri Sri Tattva Chyawanprash , Sri Sri Tattva Immugen) for Screening inhibitors of the SARS-COV-2 Spike: ACE2 interaction.
With not a single adverse event, the trial confirmed the safety and tolerability of AYUSH medicines including Sri Sri Tattva Kabasura Kudineer tablets, Shakti Drops and Turmeric plus tablets (Sri Sri Tattva proprietary medicines), for use among patients with mild symptoms.
Superoxide dismutase (SOD), Catalase (CAT), Malondialdehyde (MDA), Glutathione (GSH) after 14 days of treatment with Sri Sri Tattva Immunity Products along with Standard of care.